Your browser doesn't support javascript.
loading
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.
Zuurbier, Linda; Rahman, Arman; Cordes, Martijn; Scheick, Jennifer; Wong, Tse J; Rustenburg, François; Joseph, Jesu Christopher; Dynoodt, Peter; Casey, Rory; Drillenburg, Paul; Gerhards, Michael; Barat, Ana; Klinger, Rut; Fender, Bozena; O'Connor, Darran P; Betge, Johannes; Ebert, Matthias P; Gaiser, Timo; Prehn, Jochen H M; Griffioen, Arjan W; van Grieken, Nicole C T; Ylstra, Bauke; Byrne, Annette T; van der Flier, Laurens G; Gallagher, William M; Postel, Ruben.
Afiliação
  • Zuurbier L; SomantiX BV, Utrecht, The Netherlands.
  • Rahman A; OncoMark Ltd, Dublin, Ireland.
  • Cordes M; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Scheick J; Department of Medical Oncology, Angiogenesis Laboratory, VU University Medical Center, Amsterdam, The Netherlands.
  • Wong TJ; Department of Medical Oncology, Angiogenesis Laboratory, VU University Medical Center, Amsterdam, The Netherlands.
  • Rustenburg F; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Joseph JC; OncoMark Ltd, Dublin, Ireland.
  • Dynoodt P; OncoMark Ltd, Dublin, Ireland.
  • Casey R; OncoMark Ltd, Dublin, Ireland.
  • Drillenburg P; Department of Pathology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Gerhards M; Department of Pathology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
  • Barat A; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Klinger R; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
  • Fender B; OncoMark Ltd, Dublin, Ireland.
  • O'Connor DP; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Betge J; Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Ebert MP; Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Gaiser T; Institute of Pathology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Prehn JHM; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Griffioen AW; Department of Medical Oncology, Angiogenesis Laboratory, VU University Medical Center, Amsterdam, The Netherlands.
  • van Grieken NCT; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Ylstra B; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Byrne AT; Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • van der Flier LG; SomantiX BV, Utrecht, The Netherlands.
  • Gallagher WM; OncoMark Ltd, Dublin, Ireland.
  • Postel R; UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland.
Oncotarget ; 8(26): 42949-42961, 2017 Jun 27.
Article em En | MEDLINE | ID: mdl-28487489
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Bevacizumab / Apelina / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Bevacizumab / Apelina / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda